Cargando…

Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan

BACKGROUND: Sorafenib is the first regimen listed in the treatment algorithm for hepatocellular carcinoma (HCC) worldwide. This study aimed to assess the efficacy of sorafenib treatment for advanced HCC in a clinical practice using a nationwide population study. METHODS: All patients registered with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Kun-Ming, Wu, Tsung-Han, Cheng, Chih-Hsien, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Lee, Wei-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349081/ https://www.ncbi.nlm.nih.gov/pubmed/30774429 http://dx.doi.org/10.2147/CMAR.S186678

Ejemplares similares

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

Impact of donor with evidence of bacterial infections on deceased donor liver transplantation: a retrospective observational cohort study in Taiwan
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma
por: Lee, Wei-Chen, et al.
Publicado: (2019)

Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma
por: Wu, Tsung-Han, et al.
Publicado: (2020)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma
por: Hsiao, Pojen, et al.
Publicado: (2019)

Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment
por: Wang, Yu-Chao, et al.
Publicado: (2021)

Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
por: Chan, Kun-Ming, et al.
Publicado: (2023)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014)

Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
por: Lee, Jin-Chiao, et al.
Publicado: (2021)

Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival
por: Hung, Hao-Chien, et al.
Publicado: (2022)

Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan
por: Chen, Yi-Chan, et al.
Publicado: (2016)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
por: Huang, Song-Fong, et al.
Publicado: (2022)

Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

De Novo Endotoxin-Induced Production of Antibodies against the Bile Salt Export Pump Associated with Bacterial Infection following Major Hepatectomy
por: Chan, Kun-Ming, et al.
Publicado: (2018)

“Left at right” liver transplantation with heterotopic implantation of left liver graft in the right subphrenic space: Reappraisal and technical concerns for decision making
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive Surgery
por: Wu, Tsung-Han, et al.
Publicado: (2022)

Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
por: Cheng, Tsung-Yi, et al.
Publicado: (2020)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Individualized Selection Criteria Based on Tumor Burden in Future Remnant Liver for Staged Hepatectomy of Advanced CRLM: Conventional TSH or ALPPS
por: Chan, Kun-Ming, et al.
Publicado: (2022)

Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Encouraging Split Liver Transplantation for Two Adult Recipients to Mitigate the High Incidence of Wait-List Mortality in the Setting of Extreme Shortage of Deceased Donors
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy
por: Soong, Ruey-Shyang, et al.
Publicado: (2011)

The Preference for Anterior Approach Major Hepatectomy: Experience Over 3 Decades and a Propensity Score-Matching Analysis in Right Hepatectomy for Hepatocellular Carcinoma
por: Chan, Kun-Ming, et al.
Publicado: (2015)

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
por: Thorat, Ashok, et al.
Publicado: (2014)

Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis
por: Chen, Ming-Yang, et al.
Publicado: (2016)

Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma
por: Yu, Ming-Chin, et al.
Publicado: (2021)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

Adult Living Donor Liver Transplantation Across ABO-Incompatibility
por: Lee, Chen-Fang, et al.
Publicado: (2015)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

A review of split liver transplantation with full right/left hemi-liver grafts for 2 adult recipients
por: Chan, Kun-Ming, et al.
Publicado: (2021)

Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
por: Lee, Chen-Fang, et al.
Publicado: (2021)

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
por: Lee, Wei-Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_259a8v5cs1dqnife8lhuopmm9j